Juliette Saillard
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial.
Journal: Scientific reports
Published: August 27, 2024
Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20-15 DisCoVeRy study.
Journal: Contemporary clinical trials
Published: February 03, 2023
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Journal: Pharmacology research & perspectives
Published: November 29, 2022
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: August 25, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 17, 2021
Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).
Journal: British journal of clinical pharmacology
Published: July 06, 2020
Practices in research, surveillance and control of neglected tropical diseases by One Health approaches: A survey targeting scientists from French-speaking countries.
Journal: PLoS neglected tropical diseases
Published: June 03, 2020
Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.
Journal: British journal of clinical pharmacology
Published: June 12, 2018
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
Journal: The Journal of antimicrobial chemotherapy
Published: March 01, 2018
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
Journal: The Journal of antimicrobial chemotherapy
Published: February 16, 2018
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
Journal: The Journal of antimicrobial chemotherapy
Published: July 12, 2017
Prevalence and Genetics of Leber Hereditary Optic Neuropathy in the Danish Population.
Journal: Investigative ophthalmology & visual science
Published: March 24, 2016
Last Updated: 09/26/2026